Ser Educacional (SEER3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Achieved double-digit growth in the hybrid education student base, with hybrid learning up 10.4% and medical student base up 12.3%, optimizing property occupancy and expanding Adjusted EBITDA margin by 2.9 percentage points to 26.3%, with Adjusted EBITDA up 22.8% year-over-year.
Adjusted net income surged 112.1% year-over-year to R$76.9 million, reversing a BRL 30 million loss to a BRL 74.6 million profit.
Reduced financial indebtedness by nearly 30% year-over-year, reaching the lowest leverage since Q1 2021, with net debt/adjusted EBITDA down to 0.90x.
Operational optimization, asset-light organic growth, and expansion in promising markets with six new units operational and further expansion planned in secondary cities.
Robust cash generation, with net operating cash generation post-CapEx up 227.9% to R$74.5 million, enabling resumed shareholder dividends.
Financial highlights
Consolidated net revenue increased 9.4% year-over-year in Q4 to R$572.9 million, with hybrid education revenue up 12.3% to R$463.7 million and other revenues up 25.8%.
Adjusted EBITDA margin expanded by 2.9 percentage points, closing the year slightly above 25% and reaching 26.3% in 4Q25.
Net income reversed from a BRL 30 million loss to a BRL 74.6 million profit, with recurring net income nearly doubling year-over-year.
Operating cash generation grew 94.5% pre-CapEx and 228% post-CapEx, driven by improved payment punctuality and anticipation of receivables.
CapEx decreased to R$23.0 million, representing 4.0% of net revenues.
Outlook and guidance
Focus for 2026 is on maintaining operating leverage, gradual technology adoption, organic expansion, new unit openings, and medical course expansion, especially in healthcare programs and secondary cities.
CapEx expected to return to historical average of 5%-6% of net revenue, supporting asset-light expansion and new unit openings.
Dividend policy reinstated, targeting semi-annual payments of 30% of net earnings, with R$61 million paid.
Leverage targeted between 0.6 and 0.8, balancing growth and shareholder returns.
Continued emphasis on reducing financial leverage and optimizing course portfolio.
Latest events from Ser Educacional
- Adjusted net income rose 8.5% to R$46.2M, with strong hybrid and health course growth.SEER3
Q2 20242 Feb 2026 - Revenue and EBITDA surged as leverage fell, led by health and medicine course expansion.SEER3
Q3 202414 Jan 2026 - Strong earnings, cash generation, and medical course expansion drive margin and debt improvement.SEER3
Q4 202427 Dec 2025 - Record profitability in 1Q25 fueled by hybrid and medical education growth and margin gains.SEER3
Q1 202526 Nov 2025 - Net income up 66.4%, hybrid enrollment up 13.8%, and net debt/EBITDA down to 1.24x.SEER3
Q2 202523 Nov 2025 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025 - Hybrid learning growth and operational gains drove profitability and lower net debt in Q1 2024.SEER3
Q1 20243 Jun 2025